Anticancer effects and possible mechanisms of lycopene intervention on N-methylbenzylnitrosamine induced esophageal cancer in F344 rats based on PPARγ1

Eur J Pharmacol. 2020 Aug 15:881:173230. doi: 10.1016/j.ejphar.2020.173230. Epub 2020 Jun 14.

Abstract

Lycopene, a natural carotenoid, has potential chemopreventive effects in many cancers. This study aimed to examine the effects of lycopene on regulating the inflammation and apoptosis of N-nitrosomethylbenzylamine(NMBzA) induced esophageal cancer in F344 rats. After the rats were fed normal diets containing different concentrations of lycopene for 25 weeks (10, 25, 50 mg/kg·d of lycopene, respectively), the incidence of tumors in the rats treated with lycopene was significantly lower than that in the simple exposed group (P < 0.05). The antioxidant activity of lycopene was exerted by measuring the levels of GSH-PX, SOD and MDA activity by oxidative stress kits. Furthermore, through western blotting analysis lycopene intervention was found to have significantly improved apoptosis cytokines by increasing the protein expression levels of PPARγ and caspase-3, and also significantly reduced inflammatory cytokines by decreasing the protein expression of NF-κB and COX-2 in the esophagus tissue, especially in the 25 mg/kg of lycopene intervention group (all P < 0.05). These results demonstrated that appropriate dose of lycopene intervention could inhibit the carcinogenesis of esophageal in F344 rats through the possible mechanisms of anti-inflammatory and pro-apoptosis.

Keywords: Anti-inflammation; Esophageal cancer; F344 rat; Lycopene; Pro-apoptosis.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anticarcinogenic Agents / pharmacology*
  • Antioxidants / pharmacology
  • Apoptosis / drug effects
  • Cell Transformation, Neoplastic / chemically induced
  • Cell Transformation, Neoplastic / drug effects*
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology
  • Cyclooxygenase 2 / metabolism
  • Dimethylnitrosamine / analogs & derivatives
  • Disease Models, Animal
  • Esophageal Neoplasms / chemically induced
  • Esophageal Neoplasms / metabolism
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / prevention & control*
  • Esophagus / drug effects*
  • Esophagus / metabolism
  • Esophagus / pathology
  • Inflammation Mediators / metabolism
  • Lycopene / pharmacology*
  • Male
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • PPAR gamma / metabolism
  • Rats, Inbred F344
  • Signal Transduction

Substances

  • Anti-Inflammatory Agents
  • Anticarcinogenic Agents
  • Antioxidants
  • Inflammation Mediators
  • NF-kappa B
  • PPAR gamma
  • PPARG protein, human
  • nitrosobenzylmethylamine
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • Dimethylnitrosamine
  • Lycopene